Evaluation of histomorphological findings and malignancies in postmenopausal bleeding

---

Original Article

Author Details : M. Pavani, Ch. Geetha, L. Peter Ericson, Ashok Kumar Deshpande

Volume : 5, Issue : 2, Year : 2018

Article Page : 302-307

https://doi.org/10.18231/2394-6792.2018.0057

Suggest article by email

Get Permission

---

Abstract

Introduction: In this era, as the life expectancy is increasing, women are experiencing a long postmenopausal phase. Postmenopausal bleeding (PMB) is a sinister complaint and accounts for about 10% of postmenopausal complaints. Being a symptom of varied etiologies and its strong association with malignancy, it should be diligently evaluated.
Aims and Objectives: 1. To evaluate the histopathological spectrum of lesions presenting as PMB. 2. To estimate the incidence of premalignant, and malignant lesions presenting as PMB. 3. To confirm the benign nature of the lesions to prevent unnecessary radical treatment.
Materials and Methods: This prospective study done from January 2016 to September 2017 and included the endometrial biopsies/curettages and cervical biopsies sent for histopathological examination from clinically diagnosed cases of postmenopausal bleeding.
Results: Out of all the samples majority were benign lesions (44%), followed by premalignant (25.7%), malignant lesions (18.3%).
Conclusion: A variety of histopathological findings are seen in PMB.
Benign pathologies were more common in our study but the collective proportion of premalignant and malignant lesions is considerably higher in this study.
Accurate diagnosis makes it much easier to counsel the patient about further course of management, prevent unnecessary radical treatment for benign conditions, prompt treatment, and vigilant follow up for malignant lesions.

Keywords: Postmenopausal bleeding (PMB), Endometrial carcinoma, Histopathology.

How to cite : Pavani M, Geetha C, Ericson L P, Deshpande A K, Evaluation of histomorphological findings and malignancies in postmenopausal bleeding. Indian J Pathol Oncol 2018;5(2):302-307

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.